These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D; Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368 [TBL] [Abstract][Full Text] [Related]
3. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years. Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form. Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897 [TBL] [Abstract][Full Text] [Related]
5. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632 [TBL] [Abstract][Full Text] [Related]
6. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry. Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138 [TBL] [Abstract][Full Text] [Related]
7. Long-term prospective study of recurrent venous thromboembolism in a Hispanic population. Mello TB; Orsi FL; Montalvao SA; Ozelo MC; de Paula EV; Annichinno-Bizzachi JM Blood Coagul Fibrinolysis; 2010 Oct; 21(7):660-5. PubMed ID: 20829682 [TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity. Strandberg K; Svensson PJ; Ohlin AK Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343 [TBL] [Abstract][Full Text] [Related]
9. Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy. Andresen MS; Sandven I; Brunborg C; Njaastad AM; Strekerud F; Abdelnoor M; Smith P; Abildgaard U Thromb Res; 2011 Jun; 127(6):540-6. PubMed ID: 21435698 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives. Vaillant-Roussel H; Ouchchane L; Dauphin C; Philippe P; Ruivard M Contraception; 2011 Nov; 84(5):e23-30. PubMed ID: 22018134 [TBL] [Abstract][Full Text] [Related]
11. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. White RH; Chan WS; Zhou H; Ginsberg JS Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344 [TBL] [Abstract][Full Text] [Related]
12. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study. Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893 [TBL] [Abstract][Full Text] [Related]
13. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. García-Fuster MJ; Forner MJ; Fernández C; Gil J; Vaya A; Maldonado L Pathophysiol Haemost Thromb; 2005; 34(1):6-12. PubMed ID: 16293979 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Holst AG; Jensen G; Prescott E Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252 [TBL] [Abstract][Full Text] [Related]
15. Gender and the risk of venous thromboembolism. Tormene D; Ferri V; Carraro S; Simioni P Semin Thromb Hemost; 2011 Apr; 37(3):193-8. PubMed ID: 21455853 [TBL] [Abstract][Full Text] [Related]
16. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia. Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M; Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227 [TBL] [Abstract][Full Text] [Related]
17. [The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results]. Schramm W; Heinemann LA; Spannagl M; Dick A; Assmann A Dtsch Med Wochenschr; 2000 Jan; 125(1-2):2-6. PubMed ID: 10650817 [TBL] [Abstract][Full Text] [Related]
19. Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Severinsen MT; Johnsen SP; Tjønneland A; Overvad K; Dethlefsen C; Kristensen SR Eur J Intern Med; 2010 Aug; 21(4):268-72. PubMed ID: 20603033 [TBL] [Abstract][Full Text] [Related]
20. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]